Gemina Laboratories Ltd.
GLABF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Market Cap | $47 | $41 | $42 | $25 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $1 | $0 | $0 | $0 |
| Enterprise Value | $49 | $41 | $42 | $24 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$4 | -$5 | -$6 | -$5 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$5 | -$6 | -$5 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.055 | -0.072 | -0.099 | -0.099 |
| % Growth | 23.6% | 27.5% | 0.1% | – |
| Operating Cash Flow | -$1 | -$3 | -$5 | -$4 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$3 | -$5 | -$4 |